Login / Signup

Letter: the potential risk of HBV reactivation in patients with resolved HBV infection during direct-acting antiviral therapy - authors' reply.

M M MückeV T MückeJohannes Vermehren
Published in: Alimentary pharmacology & therapeutics (2017)
Keyphrases
  • hepatitis b virus
  • liver failure
  • human health
  • risk assessment
  • mesenchymal stem cells
  • climate change